Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nicotine 15mg inhalation cartridges with device
0410020B0AABZBZ
|
Nicotine | Nicotine | Central Nervous System | 12,187 |
|
Nicotine 21mg/24hours transdermal patches
0410020B0AAARAR
|
Nicotine | Nicotine | Central Nervous System | 10,170 |
|
Nicotine 25mg/16hours transdermal patches
0410020B0AABRBR
|
Nicotine | Nicotine | Central Nervous System | 7,565 |
|
Nicotine 15mg/16hours transdermal patches
0410020B0AAAUAU
|
Nicotine | Nicotine | Central Nervous System | 6,198 |
|
Nicotine 1mg/dose oromucosal spray sugar free
0410020B0AABWBW
|
Nicotine | Nicotine | Central Nervous System | 4,888 |
|
Nicotine 14mg/24hours transdermal patches
0410020B0AAAQAQ
|
Nicotine | Nicotine | Central Nervous System | 4,831 |
|
Nicotine 10mg/16hours transdermal patches
0410020B0AAATAT
|
Nicotine | Nicotine | Central Nervous System | 2,979 |
|
Nicotine 2mg medicated chewing gum sugar free
0410020B0AABABA
|
Nicotine | Nicotine | Central Nervous System | 2,760 |
|
Nicotine 4mg medicated chewing gum sugar free
0410020B0AABDBD
|
Nicotine | Nicotine | Central Nervous System | 2,243 |
|
Nicotine 2mg lozenges sugar free
0410020B0AAAYAY
|
Nicotine | Nicotine | Central Nervous System | 2,137 |
|
Nicotine 7mg/24hours transdermal patches
0410020B0AAAPAP
|
Nicotine | Nicotine | Central Nervous System | 2,066 |
|
Nicotine 4mg lozenges sugar free
0410020B0AAAZAZ
|
Nicotine | Nicotine | Central Nervous System | 1,139 |
|
Nicotine 500micrograms/dose nasal spray
0410020B0AAANAN
|
Nicotine | Nicotine | Central Nervous System | 664 |
|
Nicotine 2mg sublingual tablets sugar free
0410020B0AAAWAW
|
Nicotine | Nicotine | Central Nervous System | 419 |
|
Nicotine 1.5mg lozenges sugar free
0410020B0AABPBP
|
Nicotine | Nicotine | Central Nervous System | 231 |
|
Nicotine 450micrograms/dose inhaler CFC free
0410020B0AACDCD
|
Nicotine | Nicotine | Central Nervous System | 56 |
|
Nicotine 6mg medicated chewing gum sugar free
0410020B0AACCCC
|
Nicotine | Nicotine | Central Nervous System | 2 |
|
Nicotine 10mg inhalation cartridges with device
0410020B0AAAVAV
|
Nicotine | Nicotine | Central Nervous System | No data available |
|
Nicotine 15mg/16 hours ptch and Nicotine 2mg chewing gum SF
0410020B0AABUBU
|
Nicotine | Nicotine | Central Nervous System | No data available |
|
Nicotine 2.5mg orodispersible films sugar free
0410020B0AACACA
|
Nicotine | Nicotine | Central Nervous System | No data available |
|
Nicotine 5mg/16hours transdermal patches
0410020B0AAASAS
|
Nicotine | Nicotine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.